Diagnostic performance of 18F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer ...
E. W. Webster, Ph.D. Assistant in radiology, Harvard Medical School; physicist, Department of Radiology, Massachusetts General Hospital. O. E. Merrill, B.E.E., R.T ...
Baseline plasma HA in PDA versus healthy subjects and effects of PEGPH20 on plasma HA in PDA subjects treated with GEM/NAB. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This ...